Mylab expands production capacity of COVID-19 testing kits to enable 2 lakh tests per day
Until now, Mylab has already manufactured testing kits for conducting 6.5 lakh tests and has supplied them to 140 sites, including labs and hospitals in over 20 states, Mylab said in a statement.
As per the production plan, the company is scaling-up its manufacturing to enable 2 lakh tests per day, it added.
"It overwhelms me to see our efforts with Mylab in making India self-reliant in combating COVID-19 fructified," Serum Institute of India CEO Adar Poonawalla said.
As the production capacity increases from 20,000 tests per day to 2 lakh COVID-19 tests a day, "we will now be able to meet India's growing demand for testing completely," he added.
The company has also received approval from Indian Council of Medical Research (ICMR) for its RNA extraction kit Maverick to further streamline the RT-PCR testing process, Mylab said.
"We aim to make India self-reliant with high-quality testing. As we ramp-up our production, our focus on quality is more than ever," Mylab Discovery Solutions MD Hasmukh Rawal said.In early April, Mylab had said that it has partnered with Adar Poonawalla and Abhijit Pawar to scale up the operations and escalate faster delivery of the COVID-19 testing kits. AKT BAL
(This story has not been edited by Business Insider and is auto-generated from a syndicated feed we subscribe to.)
- Fintech unicorn CRED to acquire SaaS startup CreditVidya
- Jio Haptik and CASHe partner to deliver instant credit lines on Whatsapp
- Dharmaj Crop Guard IPO subscribed 5.97 times on day 2
- Recent IPO successes could lead to recovery in the primary market: E&Y
- Capex cycle to touch ₹21 lakh crore in FY23, but there's a catch